Strategy of treatment for hepatocellular carcinomas with vascular infiltration in patients undergoing hepatectomy

Journal of Surgical Oncology

Volumn 101, Issue 7, 2010, Pages 557-563

  Nanashima, Atsushi ^a   Tobinaga, Syuuichi ^a   Kunizaki, Masaki ^a   Miuma, Satoshi ^a   Taura, Naota ^a   Takeshita, Hiroaki ^a   Hidaka, Shigekazu ^a   Sawai, Terumitsu ^a   Nakao, Kazuhiko ^a   Nagayasu, Takeshi ^a  

^a NAGASAKI UNIVERSITY HOSPITAL   (Japan)

Author keywords

Hepatic resection; Hepatocellular carcinoma; Surgical margin; Vascular infiltration

Indexed keywords

ADULT; AGED; ARTICLE; BILE DUCT; DISEASE FREE SURVIVAL; FEMALE; HEPATIC VEIN; HUMAN; LIVER CELL CARCINOMA; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PORTAL VEIN; PRIORITY JOURNAL; TREATMENT PLANNING; VASCULAR DISEASE; VASCULAR INFILTRATION;

ADULT; AGED; AGED, 80 AND OVER; BILE DUCTS; BIOLOGICAL MARKERS; CARCINOMA, HEPATOCELLULAR; FEMALE; HEPATECTOMY; HEPATIC VEINS; HUMANS; JAPAN; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASTIC CELLS, CIRCULATING; PATIENT SELECTION; PORTAL VEIN; PROGNOSIS; PROTEIN PRECURSORS; PROTHROMBIN; SURVIVAL ANALYSIS;

EID: 77952047327     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.21534     Document Type: Article

References (49)

1. Yamamoto J, Okada S, Shimada K, et al.: Treatment strategy for small hepatocellular carcinoma: Comparison of long-term results after percutaneous ethanol injection therapy and surgical resection. Hepatology 2001;34:707-714.
2. Arii S, Yamaoka Y, Futagawa S, et al.: Results of surgical and non-surgical treatment for small-sized hepatocellular carcinomas: A retrospective and nationwide survey in Japan. The Liver Cancer Study Group of Japan. Hepatology 2000;32:1224-1229.
3. Kumada T, Nakano S, Takeda I, et al.: Patterns of recurrence after initial treatment in patients with small hepatocellular carcinoma. Hepatology 1997;25:87-92.
4. Arii S, Tanaka J, Yamazoe Y, et al.: Predictive factors for intrahepatic recurrence of hepatocellular carcinoma after partial hepatectomy. Cancer 1992;69:913-919.
5. Poon RT, Fan ST: Hepatectomy for hepatocellular carcinoma: Patient selection and postoperative outcome. Liver Transplant 2004;10:39-45.
6. Machado MA, Herman P, Machado MC: A standardized technique for right segmental liver resections. Arch Surg 2003;138:918-920. (Pubitemid 36960958)
7. Van Deusen MA, Abdalla EK, Vauthey JN, et al.: Staging classifications for hepatocellular carcinoma. Expert Rev Mol Diagn 2005;5:377-383.
8. Bhattacharjya S, Bhattacharjya T, Quaglia A, et al.: Liver transplantation in cirrhotic patients with small hepatocellular carcinoma: An analysis of pre-operative imaging, explant histology and prognostic histologic indicators. Dig Surg 2004;21:152-159.
9. Fan ST, Ng I, Poon R, et al.: Hepatectomy for hepatocellular carcinoma. The surgeon's role in long-term survival. Arch Surg 1999;134:1124-1130.
10. Imamura H, Matsuyama Y, Miyagawa Y, et al.: Prognostic significance of anatomical resection and des-gamma-carboxy prothrombin in patients with hepatocellular carcinoma. Br J Surg 1999;86:1032-1038. (Pubitemid 29387069)
11. Shirabe K, Kajiyama K, Abe T, et al.: Predictors of microscopic portal vein invasion by hepatocellular carcinoma: Measurement of portal perfusion defect area ratio. J Gastroenterol Hepatol 2009;24:1431-1436.
12. Miyaaki H, Nakashima O, Kurogi M, et al.: Lens culinaris agglutinin-reactive alpha-fetoprotein and protein induced by vitamin K absence II are potential indicators of a poor prognosis: A histopathological study of surgically resected hepatocellular carcinoma. J Gastroenterol 2007;42:962-968.
13. Takasaki T, Kobayashi S, Suzuki S, et al.: Predetermining postoperative hepatic function for hepatectomies. Int Surg 1980;65:309-313. (Pubitemid 12155191)
14. Miyagawa S, Makuuchi M, Kawasaki S, et al.: Criteria for safe hepatic resection. Am J Surg 1995;169:589-594.
15. Kubota K, Makuuchi M, Kusaka K, et al.: Measurement of liver volume and hepatic functional reserve as a guide to decisionmaking in resection surgery for hepatic tumors. Hepatology 1997;26:1176-1181.
16. Liver cancer study group of Japan. Clinical findings. In: Makuuchi M. editors. General rules for the clinical and pathological study of primary liver cancer, 2nd English edition. Tokyo: Kanehara Co., Ltd.; 2003. pp. 5-28.
17. Tamano M, Sugaya H, Oguma M, et al.: Serum and tissue PIVKA-II expression reflect the biological malignant potential of small hepatocellular carcinoma. Hepatol Res 2002;22:261-269.
18. Tanaka S, Mogushi K, Yasen M, et al.: Surgical contribution to recurrence-free survival in patients with macrovascular-invasion-negative hepatocellular carcinoma. J Am Coll Surg 2009;208:368-374.
19. Sumie S, Kuromatsu R, Okuda K, et al.: Microvascular invasion in patients with hepatocellular carcinoma and its predictable clinicopathological factors. Ann Surg Oncol 2008;15:1375-1382.
20. Nathan H, Schulick RD, Choti MA, et al.: Predictors of survival after resection of early hepatocellular carcinoma. Ann Surg 2009;249:799-805.
21. Kaibori M, Ishizaki M, Saito T, et al.: Risk factors and outcome of early recurrence after resection of small hepatocellular carcinomas. Am J Surg 2009;198:39-45.
22. Hakamada K, Kimura N, Miura T, et al.: Des-gamma-carboxy prothrombin as an important prognostic indicator in patients with small hepatocellular carcinoma. World J Gastroenterol 2008;14:1370-1377.
23. Shah SA, Greig PD, Gallinger S, et al.: Factors associated with early recurrence after resection for hepatocellular carcinoma and outcomes. J Am Coll Surg 2006;202:275-283.
24. Kondo K, Chijiiwa K, Makino I, et al.: Risk factors for early death after liver resection in patients with solitary hepatocellular carcinoma. J Hepatobiliary Pancreat Surg 2005;12:399-404.
25. Tung-Ping Poon R, Fan ST,Wong J: Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma. Ann Surg 2000;232:10-24. (Pubitemid 30456545)
26. Shimozawa N, Hanazaki K: Longterm prognosis after hepatic resection for small hepatocellular carcinoma. J Am Coll Surg 2004;198:356-365. (Pubitemid 38283726)
27. Yamamoto J, Kosuge T, Saiura A, et al.: Effectiveness of hepatic resection for early-stage hepatocellular carcinoma in cirrhotic patients: Subgroup analysis according to Milan criteria. Jpn J Clin Oncol 2007;37:287-295.
28. Fukuda S, Itamoto T, Nakahara H, et al.: Clinicopathologic features and prognostic factors of resected solitary small-sized hepatocellular carcinoma. Hepatogastroenterology 2005;52:1163-1167.
29. Yeh CN, Jan YY, Lee WC, et al.: Hepatic resection for hepatocellular carcinoma with obstructive jaundice due to biliary tumor thrombi. World J Surg 2004;28:471-475.
30. Nagano Y, Shimada H, Takeda K, et al.: Predictive factors of microvascular invasion in patients with hepatocellular carcinoma larger than 5cm. World J Surg 2008;32:2218-2222.
31. Sakata J, Shirai Y, Wakai T, et al.: Preoperative predictors of vascular invasion in hepatocellular carcinoma. Eur J Surg Oncol 2008;34:900-905.
32. Kiyosawa K, Umemura T, Ichijo T, et al.: Hepatocellular carcinoma: Recent trends in Japan. Gastroenterology 2004;127:S17-S26.
33. Hasegawa K, Imamura H, Ijichi M, et al.: Inclusion of tumor markers improves the correlation of the Milan criteria with vascular invasion and tumor cell differentiation in patients with hepatocellular carcinoma undergoing liver resection. J Gastrointest Surg 2008;12:858-866.
34. Matsuda M, Suzuki T, Kono H, et al.: Predictors of hepatic venous trunk invasion and prognostic factors in patients with hepatocellular carcinomas that had come into contact with the trunk of major hepatic veins. J Hepatobiliary Pancreat Surg 2007;14:289-296. (Pubitemid 46863919)
35. Pawlik TM, Delman KA, Vauthey JN, et al.: Tumor size predicts vascular invasion and histologic grade: Implications for selection of surgical treatment for hepatocellular carcinoma. Liver Transpl 2005;11:1086-1192.
36. Korenaga K, Korenaga M, Furukawa M, et al.: Usefulness of Sonazoid contrast-enhanced ultrasonography for hepatocellular carcinoma: Comparison with pathological diagnosis and superparamagnetic iron oxide magnetic resonance images. J Gastroenterol 2009;44:733-741.
37. Qin LX, Tang ZY: The prognostic significance of clinical and pathological features in hepatocellular carcinoma. World J Gastroenterol 2002;8:193-199. (Pubitemid 34414863)
38. Mazzaferro V, Chun YS, Poon RT, et al.: Liver transplantation for hepatocellular carcinoma. Ann Surg Oncol 2008;15:1001-1007.
39. Zhou L, Liu J, Luo F: Serum tumor markers for detection of hepatocellular carcinoma. World J Gastroenterol 2006;12:1175-1181.
40. Nanashima A, Sumida Y, Tobinaga S, et al.: Postoperative changes in protein-induced vitamin K absence or antagonist II levels after hepatectomy in patients with hepatocellular carcinoma: Relationship to prognosis. HPB 2006;8:137-141.
41. Nakagawa T, Seki T, Shiro T, et al.: Clinicopathologic significance of protein induced vitamin K absence or antagonist II and alpha-fetoprotein in hepatocellular carcinoma. Int J Oncol 1999;14:281-286.
42. Okuda H, Nakanishi T, Takatsu K, et al.: Clinicopathologic features of patients with hepatocellular carcinoma seropositive for alpha-fetoprotein-L3 and seronegative for des-gamma-carboxy prothrombin in comparison with those seropositive for des-gamma-carboxy prothrombin alone. J Gastroenterol Hepatol 2002;17:772-778.
43. Omagari K, Honda S, Kadokawa Y, et al.: Preliminary analysis of a newly proposed prognostic scoring system (SLiDe score) for hepatocellular carcinoma. J Gastroenterol Hepatol 2004;19:805-811.
44. Nanashima A, Sumida Y, Tobinaga S, et al.: Postoperative changes in protein-induced vitamin K absence or antagonist II levels after hepatectomy in patients with hepatocellular carcinoma: Relationship to prognosis. HPB 2006;8:137-141.
45. Makuuchi M, Hasegawa H, Yamazaki S: Ultrasonically guided subsegmentectomy. Surg Gynecol Obstet 1985;161:346-350.
46. Kanematsu T, Takenaka K, Matsumata T, et al.: Limited hepatic resection effective for selected cirrhotic patients with primary liver cancer. Ann Surg 1984;199:51-56. (Pubitemid 14218874)
47. Wakai T, Shirai Y, Sakata J, et al.: Anatomic resection independently improves long-term survival in patients with T1-T2 hepatocellular carcinoma. Ann Surg Oncol 2007;14:1356-1365. (Pubitemid 46536830)
48. Tanaka K, Shimada H, Matsumoto C, et al.: Anatomic versus limited nonanatomic resection for solitary hepatocellular carcinoma. Surgery 2008;143:607-615.
49. Eguchi S, Kanematsu T, Arii S, et al.: Liver Cancer Study Group of Japan. Comparison of the outcomes between an anatomical subsegmentectomy and a non-anatomical minor hepatectomy for single hepatocellular carcinomas based on a Japanese nationwide survey. Surgery 2008;143:469-475.